NPPA asks state drug controllers to prevent hoarding, black marketing of medical oxygen
Advertisement
New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has written a letter to all state drug controllers to take strong action to prevent hoarding and black marketing of medical oxygen in their states. In the letter, NPPA Chairperson Shubhra Singh said the increase in number of COVID-19 cases in the country has resulted in surge of demand for medical oxygen.
"The government is committed to ensuring uninterrupted supply of medical oxygen. Many of the states/UTs are dependent o Many of the states/UTs are dependent on the medical oxygen supply from other states/UTs. Hence its uninterrupted availability is of utmost importance," she added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.